Acoustic Wave Cell Therapy, Inc. (AWCT) leverages a patented acoustic pulse technology to non-invasively activate the body's natural tissue repair processes, fostering new tissue generation and organ repair. The initial focus is on treating female stress urinary incontinence—a condition currently lacking FDA-approved medication. AWCT has successfully completed two clinical trials, demonstrating efficacy comparable to surgical interventions.